Subscribe To Our Free Newsletter |
Aurobindo Pharma stock news: Analysts are bullish despite OAI to Eugia unit
Analysts say that despite OAI on Eugia unit-III, Aurobindo Pharma's Vizag facility may play a back up for unit-III and for new ANDA filings contributing to growth in FY26